SEAWOLF THERAPEUTICS
Live / Applied — Statement of use — processing complete, to examiner (as of 19 Mar 2026)
What this means for you
Not registered yet, but its 21 Oct 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97085599
- Mark type
- Stylized text
- Filed
- 21 Oct 2021
- Published for opposition
- 27 Sept 2022
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals
Owner
- Seawolf Therapeutics, Inc., San Diego, CA, US
- Seawolf Therapeutics, Inc., San Francisco, CA, US
Prosecution history
- 19 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Sept 2025 — USE AMENDMENT FILED
- 18 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Sept 2025 — SOU EXTENSION 5 GRANTED
- 07 May 2025 — SOU EXTENSION 5 FILED
- 07 May 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Sept 2024 — SOU EXTENSION 4 GRANTED
- 11 Sept 2024 — SOU EXTENSION 4 FILED
- 11 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 12 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Apr 2024 — SOU EXTENSION 3 GRANTED
- 11 Apr 2024 — SOU EXTENSION 3 FILED